Index
1 Medical Non-ionic Contrast Agent Market Overview
1.1 Product Overview and Scope of Medical Non-ionic Contrast Agent
1.2 Medical Non-ionic Contrast Agent Segment by Type
1.2.1 Global Medical Non-ionic Contrast Agent Market Value Comparison by Type (2024-2030)
1.2.2 Iopamidol Injection
1.2.3 Iodixanol Injection
1.2.4 Iohexol Injection
1.2.5 Iopromide Injection
1.2.6 Other
1.3 Medical Non-ionic Contrast Agent Segment by Application
1.3.1 Global Medical Non-ionic Contrast Agent Market Value by Application: (2024-2030)
1.3.2 CT Enhanced Scan
1.3.3 Neurography
1.3.4 Angiography
1.3.5 Arthrography
1.3.6 Other
1.4 Global Medical Non-ionic Contrast Agent Market Size Estimates and Forecasts
1.4.1 Global Medical Non-ionic Contrast Agent Revenue 2019-2030
1.4.2 Global Medical Non-ionic Contrast Agent Sales 2019-2030
1.4.3 Global Medical Non-ionic Contrast Agent Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Medical Non-ionic Contrast Agent Market Competition by Manufacturers
2.1 Global Medical Non-ionic Contrast Agent Sales Market Share by Manufacturers (2019-2024)
2.2 Global Medical Non-ionic Contrast Agent Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Medical Non-ionic Contrast Agent Average Price by Manufacturers (2019-2024)
2.4 Global Medical Non-ionic Contrast Agent Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Medical Non-ionic Contrast Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Non-ionic Contrast Agent, Product Type & Application
2.7 Medical Non-ionic Contrast Agent Market Competitive Situation and Trends
2.7.1 Medical Non-ionic Contrast Agent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Non-ionic Contrast Agent Players Market Share by Revenue
2.7.3 Global Medical Non-ionic Contrast Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Non-ionic Contrast Agent Retrospective Market Scenario by Region
3.1 Global Medical Non-ionic Contrast Agent Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Medical Non-ionic Contrast Agent Global Medical Non-ionic Contrast Agent Sales by Region: 2019-2030
3.2.1 Global Medical Non-ionic Contrast Agent Sales by Region: 2019-2024
3.2.2 Global Medical Non-ionic Contrast Agent Sales by Region: 2025-2030
3.3 Global Medical Non-ionic Contrast Agent Global Medical Non-ionic Contrast Agent Revenue by Region: 2019-2030
3.3.1 Global Medical Non-ionic Contrast Agent Revenue by Region: 2019-2024
3.3.2 Global Medical Non-ionic Contrast Agent Revenue by Region: 2025-2030
3.4 North America Medical Non-ionic Contrast Agent Market Facts & Figures by Country
3.4.1 North America Medical Non-ionic Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Medical Non-ionic Contrast Agent Sales by Country (2019-2030)
3.4.3 North America Medical Non-ionic Contrast Agent Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Non-ionic Contrast Agent Market Facts & Figures by Country
3.5.1 Europe Medical Non-ionic Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Medical Non-ionic Contrast Agent Sales by Country (2019-2030)
3.5.3 Europe Medical Non-ionic Contrast Agent Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Medical Non-ionic Contrast Agent Market Facts & Figures by Country
3.6.1 Asia Pacific Medical Non-ionic Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Medical Non-ionic Contrast Agent Sales by Country (2019-2030)
3.6.3 Asia Pacific Medical Non-ionic Contrast Agent Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Medical Non-ionic Contrast Agent Market Facts & Figures by Country
3.7.1 Latin America Medical Non-ionic Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Medical Non-ionic Contrast Agent Sales by Country (2019-2030)
3.7.3 Latin America Medical Non-ionic Contrast Agent Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Medical Non-ionic Contrast Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Non-ionic Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Medical Non-ionic Contrast Agent Sales by Country (2019-2030)
3.8.3 Middle East and Africa Medical Non-ionic Contrast Agent Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Non-ionic Contrast Agent Sales by Type (2019-2030)
4.1.1 Global Medical Non-ionic Contrast Agent Sales by Type (2019-2024)
4.1.2 Global Medical Non-ionic Contrast Agent Sales by Type (2025-2030)
4.1.3 Global Medical Non-ionic Contrast Agent Sales Market Share by Type (2019-2030)
4.2 Global Medical Non-ionic Contrast Agent Revenue by Type (2019-2030)
4.2.1 Global Medical Non-ionic Contrast Agent Revenue by Type (2019-2024)
4.2.2 Global Medical Non-ionic Contrast Agent Revenue by Type (2025-2030)
4.2.3 Global Medical Non-ionic Contrast Agent Revenue Market Share by Type (2019-2030)
4.3 Global Medical Non-ionic Contrast Agent Price by Type (2019-2030)
5 Segment by Application
5.1 Global Medical Non-ionic Contrast Agent Sales by Application (2019-2030)
5.1.1 Global Medical Non-ionic Contrast Agent Sales by Application (2019-2024)
5.1.2 Global Medical Non-ionic Contrast Agent Sales by Application (2025-2030)
5.1.3 Global Medical Non-ionic Contrast Agent Sales Market Share by Application (2019-2030)
5.2 Global Medical Non-ionic Contrast Agent Revenue by Application (2019-2030)
5.2.1 Global Medical Non-ionic Contrast Agent Revenue by Application (2019-2024)
5.2.2 Global Medical Non-ionic Contrast Agent Revenue by Application (2025-2030)
5.2.3 Global Medical Non-ionic Contrast Agent Revenue Market Share by Application (2019-2030)
5.3 Global Medical Non-ionic Contrast Agent Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GE Healthcare Medical Non-ionic Contrast Agent Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Braco
6.2.1 Braco Corporation Information
6.2.2 Braco Description and Business Overview
6.2.3 Braco Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Braco Medical Non-ionic Contrast Agent Product Portfolio
6.2.5 Braco Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer Medical Non-ionic Contrast Agent Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Guerbet
6.4.1 Guerbet Corporation Information
6.4.2 Guerbet Description and Business Overview
6.4.3 Guerbet Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Guerbet Medical Non-ionic Contrast Agent Product Portfolio
6.4.5 Guerbet Recent Developments/Updates
6.5 Leriva
6.5.1 Leriva Corporation Information
6.5.2 Leriva Description and Business Overview
6.5.3 Leriva Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Leriva Medical Non-ionic Contrast Agent Product Portfolio
6.5.5 Leriva Recent Developments/Updates
6.6 Yangtze River Pharmaceutical (Group)
6.6.1 Yangtze River Pharmaceutical (Group) Corporation Information
6.6.2 Yangtze River Pharmaceutical (Group) Description and Business Overview
6.6.3 Yangtze River Pharmaceutical (Group) Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Yangtze River Pharmaceutical (Group) Medical Non-ionic Contrast Agent Product Portfolio
6.6.5 Yangtze River Pharmaceutical (Group) Recent Developments/Updates
6.7 Jiangsu Chia Tai-Tianqing Pharmaceutical
6.6.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Corporation Information
6.6.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Description and Business Overview
6.6.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Medical Non-ionic Contrast Agent Product Portfolio
6.7.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
6.8 Jiangsu Hengrui Pharmaceuticals
6.8.1 Jiangsu Hengrui Pharmaceuticals Corporation Information
6.8.2 Jiangsu Hengrui Pharmaceuticals Description and Business Overview
6.8.3 Jiangsu Hengrui Pharmaceuticals Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Jiangsu Hengrui Pharmaceuticals Medical Non-ionic Contrast Agent Product Portfolio
6.8.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
6.9 Hainan Poly Pharm
6.9.1 Hainan Poly Pharm Corporation Information
6.9.2 Hainan Poly Pharm Description and Business Overview
6.9.3 Hainan Poly Pharm Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hainan Poly Pharm Medical Non-ionic Contrast Agent Product Portfolio
6.9.5 Hainan Poly Pharm Recent Developments/Updates
6.10 Beijing Beilu Pharmaceutical
6.10.1 Beijing Beilu Pharmaceutical Corporation Information
6.10.2 Beijing Beilu Pharmaceutical Description and Business Overview
6.10.3 Beijing Beilu Pharmaceutical Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Beijing Beilu Pharmaceutical Medical Non-ionic Contrast Agent Product Portfolio
6.10.5 Beijing Beilu Pharmaceutical Recent Developments/Updates
6.11 Zhejiang Starry Pharmaceutical
6.11.1 Zhejiang Starry Pharmaceutical Corporation Information
6.11.2 Zhejiang Starry Pharmaceutical Medical Non-ionic Contrast Agent Description and Business Overview
6.11.3 Zhejiang Starry Pharmaceutical Medical Non-ionic Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Zhejiang Starry Pharmaceutical Medical Non-ionic Contrast Agent Product Portfolio
6.11.5 Zhejiang Starry Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Non-ionic Contrast Agent Industry Chain Analysis
7.2 Medical Non-ionic Contrast Agent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Non-ionic Contrast Agent Production Mode & Process
7.4 Medical Non-ionic Contrast Agent Sales and Marketing
7.4.1 Medical Non-ionic Contrast Agent Sales Channels
7.4.2 Medical Non-ionic Contrast Agent Distributors
7.5 Medical Non-ionic Contrast Agent Customers
8 Medical Non-ionic Contrast Agent Market Dynamics
8.1 Medical Non-ionic Contrast Agent Industry Trends
8.2 Medical Non-ionic Contrast Agent Market Drivers
8.3 Medical Non-ionic Contrast Agent Market Challenges
8.4 Medical Non-ionic Contrast Agent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer